John E Levine
Pediatrics / Pediatric Hematology-Oncology · Icahn School of Medicine at Mount Sinai
Credentials: · · · · · ·
History
Research
The Lancet · 2009 · 1,949 citations
Biology of Blood and Marrow Transplantation · 2016 · Last of 25 authors · Corresponding · 880 citations
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease
Neurology · 2007 · 620 citations
91 papers
52 papers
- GY
50 papers
29 papers
29 papers
28 papers
28 papers
27 papers
Grants
- 2017–2031
BMT CTN Core - Mount Sinai Consortium
National Heart, Lung, and Blood Institute · UG1
Contact PI · $1.9M · Icahn School of Medicine at Mount Sinai
- 1997–2027
Cellular and Molecular Studies of Bone Marrow Transplant
National Cancer Institute · P01
Project lead · $8.9M · Icahn School of Medicine at Mount Sinai
- 2025–2027
Validation of a Novel and More Accurate Endpoint for GVHD Clinical Trials
National Heart, Lung, and Blood Institute · R21
Contact PI · $253.5K · Icahn School of Medicine at Mount Sinai
- 2001–2017
University of Michigan Core Clinical Center for BMT Research Network
National Heart, Lung, and Blood Institute · U10
Contact PI · $160.9K · University of Michigan at Ann Arbor
Clinical trials
- 2025–2028
- 2022–2026
- 2019–2022
- 2018–2020
Principal investigator · Completed · Phase 2
John Levine